CDC

Listed Company · HOSE

Price
22,400
Latest close
03 Apr 2026
P/E 51.0x
EPS (TTM) 439
ROE (TTM) 3.5%
P/B 1.4x
BVPS (Latest) 16,514
ROA (TTM) 0.9%

What Is Changing

CDC has not yet shown a broad-based top-line recovery. Revenue posted -11.8% YoY, but net margin reached 2.23% with an additional +0.2pp improvement versus the prior year. The next question is whether current profit momentum can hold through the next cycle.

  • Net Margin expanded consistently from 0.82% in 2023 to 2.23% in 2025.
  • Net Income growth slowed to -1.2% in 2025 from 118.9% in the prior period, at VND 23.0bn.
  • Revenue decreased 11.8% YoY to VND 1,031.0bn in 2025.
Metric 2025 2024 2023 2022 2021
Revenue 1,031.0 1,168.8 1,303.7 1,325.0 796.6
Growth -12% -10% -2% +66%
Net Income 23.0 23.3 10.7 8.6 36.6
Net Margin 2.23% 2.00% 0.82% 0.65% 4.60%

Financial Statements

Profitability

Net margin reached 2.23% while Revenue posted -11.8% YoY.

Balance Sheet

Inventory stood at 1,090.3bn, liabilities at 2,090.8bn, and equity at 871.5bn.

Cash Flow

Operating cash flow was -652.8bn in 2024, while investing cash flow was -34.4bn.

Financing cash flow: 589.7bn.

Item 2025 2024 2023 2022 2021
Net Revenue
1,031.0 1,168.8 1,303.7 1,325.0 796.6
Cost of Goods Sold
974.6 1,100.7 1,207.9 1,263.2 0.0
Gross Profit
56.5 68.1 95.8 61.9 54.0
Financial Expenses
56.1 64.2 59.5 40.3 -13.9
Selling Expenses
0.2 1.5 1.9 3.3 -1.9
General and Administrative Expenses
26.4 38.5 40.4 43.3 -28.6
Operating Profit
27.9 3.5 18.6 -5.5 32.3
Profit Before Tax
28.8 11.7 20.9 12.1 44.0
Net Income
23.0 23.3 10.7 8.6 36.6
Profit Attributable to Parent
24.0 24.0 8.6 7.0 34.3
Earnings per Share
434.00 1,094.00 389.00 188.00 837.00

Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.